Global Cosmed SA
WSE:GLC
Balance Sheet
Balance Sheet Decomposition
Global Cosmed SA
Global Cosmed SA
Balance Sheet
Global Cosmed SA
| Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||
| Cash & Cash Equivalents |
7
|
3
|
1
|
5
|
5
|
4
|
5
|
18
|
11
|
9
|
|
| Cash |
7
|
3
|
1
|
5
|
5
|
4
|
5
|
18
|
11
|
9
|
|
| Short-Term Investments |
0
|
2
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
67
|
70
|
52
|
55
|
39
|
35
|
31
|
43
|
45
|
44
|
|
| Accounts Receivables |
66
|
70
|
51
|
54
|
39
|
34
|
31
|
42
|
44
|
42
|
|
| Other Receivables |
1
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
1
|
2
|
|
| Inventory |
9
|
23
|
22
|
43
|
40
|
35
|
29
|
32
|
42
|
54
|
|
| Other Current Assets |
1
|
5
|
7
|
8
|
8
|
8
|
5
|
5
|
7
|
7
|
|
| Total Current Assets |
84
|
103
|
84
|
111
|
92
|
82
|
70
|
98
|
105
|
114
|
|
| PP&E Net |
19
|
37
|
60
|
125
|
130
|
128
|
125
|
125
|
133
|
136
|
|
| PP&E Gross |
19
|
37
|
60
|
125
|
130
|
128
|
125
|
125
|
133
|
136
|
|
| Accumulated Depreciation |
9
|
10
|
14
|
46
|
55
|
63
|
70
|
79
|
89
|
99
|
|
| Intangible Assets |
0
|
1
|
2
|
105
|
96
|
95
|
94
|
94
|
94
|
94
|
|
| Goodwill |
0
|
0
|
0
|
87
|
30
|
30
|
30
|
30
|
30
|
30
|
|
| Long-Term Investments |
1
|
0
|
1
|
0
|
0
|
0
|
2
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
1
|
3
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Assets |
0
|
0
|
0
|
87
|
30
|
30
|
30
|
30
|
30
|
30
|
|
| Total Assets |
104
N/A
|
142
+37%
|
147
+3%
|
432
+194%
|
348
-19%
|
336
-4%
|
322
-4%
|
347
+8%
|
362
+4%
|
374
+4%
|
|
| Liabilities | |||||||||||
| Accounts Payable |
21
|
34
|
21
|
48
|
49
|
56
|
42
|
38
|
61
|
67
|
|
| Accrued Liabilities |
1
|
2
|
2
|
11
|
10
|
13
|
11
|
16
|
10
|
11
|
|
| Short-Term Debt |
0
|
0
|
19
|
41
|
47
|
37
|
33
|
24
|
25
|
35
|
|
| Current Portion of Long-Term Debt |
19
|
22
|
4
|
8
|
7
|
6
|
5
|
8
|
10
|
21
|
|
| Other Current Liabilities |
1
|
2
|
1
|
9
|
8
|
7
|
8
|
7
|
6
|
4
|
|
| Total Current Liabilities |
42
|
60
|
48
|
116
|
121
|
119
|
99
|
93
|
112
|
139
|
|
| Long-Term Debt |
2
|
14
|
30
|
38
|
32
|
26
|
27
|
30
|
20
|
11
|
|
| Deferred Income Tax |
1
|
1
|
1
|
9
|
7
|
8
|
9
|
10
|
11
|
11
|
|
| Minority Interest |
0
|
0
|
0
|
1
|
4
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
1
|
1
|
1
|
2
|
2
|
2
|
2
|
|
| Total Liabilities |
46
N/A
|
77
+68%
|
80
+5%
|
163
+102%
|
164
+1%
|
155
-6%
|
137
-11%
|
135
-2%
|
144
+7%
|
162
+12%
|
|
| Equity | |||||||||||
| Common Stock |
35
|
36
|
36
|
86
|
86
|
87
|
87
|
87
|
87
|
87
|
|
| Retained Earnings |
23
|
30
|
31
|
182
|
97
|
94
|
97
|
126
|
132
|
127
|
|
| Treasury Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
|
| Other Equity |
0
|
0
|
0
|
1
|
0
|
0
|
0
|
1
|
1
|
1
|
|
| Total Equity |
58
N/A
|
66
+13%
|
67
+1%
|
269
+304%
|
184
-32%
|
181
-2%
|
184
+2%
|
212
+15%
|
217
+2%
|
213
-2%
|
|
| Total Liabilities & Equity |
104
N/A
|
142
+37%
|
147
+3%
|
432
+194%
|
348
-19%
|
336
-4%
|
322
-4%
|
347
+8%
|
362
+4%
|
374
+4%
|
|
| Shares Outstanding | |||||||||||
| Common Shares Outstanding |
36
|
36
|
36
|
86
|
86
|
86
|
87
|
87
|
87
|
87
|
|